| Followers | 19 |
| Posts | 6567 |
| Boards Moderated | 1 |
| Alias Born | 05/23/2019 |
Friday, January 20, 2023 9:24:48 AM
WISE WQLF SPECULATES ;
Why would CV Sciences go out of its way to have the 700 Preferred Group come aboard in order to vote for an Increase of Authorized Shares and Reverse Split if the company was pursuing an Acquisition or Merger? YQU don’t have to do this for an Acquisition and or Merger YQU Now Understand YQU Understand. YQU would only do it if another private company or private investor or investment group was interested in controlling the company Have Mercy Have Nordic Naturals and CV Sciences Partnership Have Faith WQLF Ahooooooo
WQLF SAID;
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170988657
Why would CV Sciences go out of its way to have the 700 Preferred Group come aboard in order to vote for an Increase of Authorized Shares and Reverse Split if the company was pursuing an Acquisition or Merger? YQU don’t have to do this for an Acquisition and or Merger YQU Now Understand YQU Understand. YQU would only do it if another private company or private investor or investment group was interested in controlling the company Have Mercy Have Nordic Naturals and CV Sciences Partnership Have Faith WQLF Ahooooooo
WQLF SAID;
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170988657
Bullish
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
